The website is currently being updated.
We apologize for any inconvenience.
Vol. 17 No. 4 (2024)
- Interim Results of the Russian Prospective Multi-Center Clinical Trial READIT-2020 (Reduction of Tyrosine Kinase Inhibitor Doses in CML Patients, Plasma Imatinib/Nilotinib Concentrations, Sustaining Molecular Response, and Drug Toxicity)
- Development and Testing of Electronic Patient-Reported Outcome System “Health – Electronic Self-Assessment” (HESA) for Monitoring the Health Status of Patients with Hematologic Malignancies Based on Their Quality-of-Life Data
Published:
01.10.2024



